301239 普瑞眼科
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.74112.2921.36410.42313.637
总资产报酬率 ROA (%)0.3546.3100.6855.39310.211
投入资产回报率 ROIC (%)0.4057.1160.7586.34413.096

边际利润分析
销售毛利率 (%)40.53743.99941.67343.37243.204
营业利润率 (%)6.11914.2033.9148.36811.700
息税前利润/营业总收入 (%)8.15215.7076.18510.95211.444
净利润/营业总收入 (%)2.81710.2291.1925.4917.997

收益指标分析
经营活动净收益/利润总额(%)107.64282.91180.92794.441104.784
价值变动净收益/利润总额(%)1.57721.61325.6126.8161.234
营业外收支净额/利润总额(%)-11.840-6.563-14.035-3.026-4.215

偿债能力分析
流动比率 (X)1.5171.1652.0400.8571.892
速动比率 (X)1.3111.0191.8550.6731.605
资产负债率 (%)51.31551.85443.77159.22426.218
带息债务/全部投入资本 (%)13.17112.43910.56211.0654.004
股东权益/带息债务 (%)412.099441.914582.388415.1282,378.783
股东权益/负债合计 (%)93.69491.783128.46268.851281.418
利息保障倍数 (X)3.0416.6022.2473.87152.699

营运能力分析
应收账款周转天数 (天)16.53511.75111.72912.57615.546
存货周转天数 (天)34.87530.64735.34931.71935.038